COVID-19
The US Food and Drug Administration (FDA) plans to swiftly add a warning about rare cases of heart inflammation in adolescents and young adults to the fact sheets of COVID-19 vaccines from pharmaceutical companies Pfizer and Moderna. According to the US Centers for Disease Control and Prevention (CDC), the inflammation
Pharmaceutical industry
A recent study published in Circulation Research reveals that immune-based therapies have transformed cancer treatments, but have also emerged as critical complications with cardiovascular sequelae. Researchers from Vanderbilt University Medical Center highlight the importance of understanding the interactions between the immune and cardiovascular systems, and the signaling cascades affected by
COVID-19
As European countries continue to ease restrictions for vaccinated travelers, COVID-19 vaccines remain available for US military personnel and their beneficiaries across the US European Command (USEUCOM) area. The vaccines have proven to be effective in reducing the risk of severe illness, hospitalization, and death from COVID-19. With the infection
Vaccines
As Taiwan faces a prolonged COVID-19 vaccine shortage, the government has authorized two top technology firms, Taiwan Semiconductor Manufacturing Co. (TSMC) and Hon Hai Precision Industry Co.'s YongLin Charity and Education Foundation, to represent it in negotiations to purchase up to 10 million doses of the BioNTech-Pfizer vaccine.
Pharmaceutical industry
The global nanomedicines market is poised for significant growth, driven by innovations in nanotechnology for medicines and the rise in prevalence of various diseases such as cardiovascular diseases, neurological diseases, infectious diseases, oncological diseases, orthopedic diseases, and others. The market is segmented into indication types, including cardiovascular diseases, neurological diseases,
Pharmaceutical industry
The global nanomedicines market is poised to experience significant growth, driven by innovations in nanotechnology for medicines and the increasing prevalence of various diseases. The market, which was valued at $130.6 billion in 2020, is expected to reach $264.6 billion by 2027, growing at a compound annual growth
Vaccines
Patients who underwent hematopoietic cell transplantation (HCT) and chimeric antigen receptor (CAR)-T therapy have shown a significantly impaired humoral response to the Pfizer/BioNTech BNT162b2 COVID-19 vaccine. In contrast, patients who underwent allogeneic HCT demonstrated a good response to the vaccine. The vaccine was well-tolerated in most patients, with
COVID-19
Concerns over rare reports of heart inflammation in people who received the Pfizer and Moderna COVID-19 vaccines have led the U.S. Centers for Disease Control and Prevention to schedule an emergency meeting. The agency has identified 226 reports, most of which have recovered, but three remain in intensive care
Pharmaceutical industry
Graft Versus Host Disease (GVHD) is a serious complication of bone marrow or stem cell transplants, where immune cells from the donor attack the recipient's tissues. The disease is commonly categorized into two types: Acute GVHD (aGVHD) and Chronic GVHD (cGVHD). The global GVHD market is expected to
COVID-19
Rutgers has announced that international students who have not been vaccinated can now receive the Pfizer, Moderna, or Johnson & Johnson vaccine upon entering the country. The University has expanded its vaccine policy to accept World Health Organization-approved vaccines for international students. This change comes after previously requiring all students
Pharmaceutical industry
The monoclonal antibodies market is expected to witness significant growth, driven by the introduction of low-priced biosimilar monoclonal antibodies and the increasing demand for targeted therapeutic monoclonal antibodies. The market, which is currently concentrated, is expected to become even more concentrated during the forecast period, with major players such as
COVID-19
California has authorized the Pfizer vaccine for children between 12 and 15 years old, following a review of the U.S. Food and Drug Administration's approval by a group of experts from California and other Western states. This announcement has been welcomed by the California Academy of Family
